Wirksamkeit des IL-17-Hemmers SECUKINUMAB bei akuter generalisierter exanthematische Pustulose (AGEP).

Clicks: 291
ID: 102142
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
gualtieri2019wirksamkeitjournal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gualtieri, Bruno;Möbs, Christian;Solimani, Farzan;Hertl, Michael;Pfützner, Wolfgang;
Journal journal der deutschen dermatologischen gesellschaft = journal of the german society of dermatology : jddg
Year 2019
DOI
10.1111/ddg.13785
URL
Keywords
efficacy safety pharmacovigilance vaccine sécurité effet indésirable ivi impfstoff nebenwirkung pharmakovigilanz sicherheit vaccin vaccino wirksamkeit adverse reaction effetti indesiderati effetto efficacité farmacovigilanza sicurezza

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.